Delivery Order SPE2DB20D2104-SPE2DB23FU90Q

Award Date 8/16/23
Potential Completion Date 9/7/23
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,352.49 Firm Fixed Price delivery order covers the supply of ERLEADA 240 MG TABLET medical products. The contract has an ultimate completion date of January 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $7,106.87 firm fixed-price delivery order is for the pharmaceutical product ERLEADA 240 MG TABLET UU 30S, with a completion date of September 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award falls under the company's existing Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,352.49 firm-fixed-price delivery order contract is for the supply of ERLEADA 240 MG TABLET UU 30S, a specialty medication. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 firm fixed-price delivery order is for the supply of ERLEADA 60 MG TABLET, a pharmaceutical product used in medical treatment. The contract has an ultimate completion date of January 8, 2025 and was awarded on December 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $14,704.98, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of ERLEADA 240 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of January 15, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,676.34 firm fixed price delivery order is for Erleada 60 mg Tablets and has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Erleada 60 mg tablets. The $7,306.27 firm-fixed-price delivery order has a completion date of November 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a broad range...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,352.49, is for the delivery of ERLEADA 240 MG TABLET UU 30S, which are pharmaceutical products. The contract has an ultimate completion date of January 24, 2025 and is a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ERLEADA 60 MG TABLET UU 120S. The $7,306.27 firm-fixed-price delivery order has a completion date of November 27, 2024 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,558.78, is for the delivery of a medical product, ERLEADA 60 MG TABLET UU 120S. This is a Firm Fixed Price Delivery Order contract with a completion date of December 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FU90Q
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,213.74 Firm Fixed Price delivery order is for the medication ERLEADA 60 MG TABLET UU 120S. The contract has an ultimate completion date of September 7, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs. This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 2/27/25, 10:58 AM